Zuckerman Investment Group, LLC Abb Vie Inc. Transaction History

Zuckerman Investment Group, LLC

$928 Million
Q3 2024

A detailed history of Zuckerman Investment Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Zuckerman Investment Group, LLC holds 76,575 shares of ABBV stock, worth $13 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

76,575

Previous 76,129 0.59%

Holding current value

$13 Million

Previous $13.1 Million 15.82%

% of portfolio

1.63%

Previous 1.56%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $73,072 - $88,901	446 Added 0.59%	76,575 $15.1 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $15,479 - $18,076	100 Added 0.13%	76,129 $13.1 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $537,155 - $612,038	3,361 Added 4.63%	76,029 $13.8 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $69,350 - $78,104	-504 Reduced 0.69%	72,668 $11.3 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $335,845 - $388,790	-2,514 Reduced 3.32%	73,172 $10.9 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $253,624 - $315,618	1,914 Added 2.59%	75,686 $10.2 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $38,321 - $44,133	-265 Reduced 0.36%	73,772 $11.8 Million
Q4 2022 Feb 15, 2023	SELL	$138.31 - $165.87 $200,687 - $240,677	-1,451 Reduced 1.92%	74,037 $12 Million
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $541,805 - $621,415	4,037 Added 5.65%	75,488 $10.1 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $164,975 - $204,687	-1,250 Reduced 1.72%	71,451 $11.6 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $144,137 - $160,577	-1,370 Reduced 1.85%	72,701 $8.19 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $23,195 - $27,224	-270 Reduced 0.36%	74,071 $6.49 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $328,257 - $439,257	-4,474 Reduced 5.68%	74,341 $7.3 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $240,004 - $363,876	3,721 Added 4.96%	78,815 $6.01 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $31,423 - $37,180	-350 Reduced 0.46%	75,094 $6.96 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $16,929 - $22,670	-184 Reduced 0.24%	75,444 $7.14 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $5.28 Million - $6.75 Million	75,628	75,628 $6.72 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zuckerman Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zuckerman Investment Group, LLC with notifications on news.

Account

Zuckerman Investment Group, LLC Abb Vie Inc. Transaction History